Eosinophilic gastrointestinal disorders (part II)
-
Upload
chulalongkorn-allergy-and-clinical-immunology-research-group -
Category
Health & Medicine
-
view
248 -
download
0
Transcript of Eosinophilic gastrointestinal disorders (part II)
![Page 1: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/1.jpg)
Eosinophilic Gastrointestinal disorders (Part II)
Yoavanit Srivaro M.D.
![Page 2: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/2.jpg)
Outline
• Eosinophilic Gastritis and Gastroenteritis
• Eosinophilic Colitis
![Page 3: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/3.jpg)
Eosinophilic Gastritis and Gastroenteritis
![Page 4: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/4.jpg)
Eosinophilic Gastritis and Gastroenteritis
• Definition
• Classification
• Epidemiology
• Etiology
• Clinical Presentation
• Diagnostic evaluation
• Treatment
![Page 5: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/5.jpg)
Definition
• characterized by selective infiltration of eosinophils
in
• stomach, small intestine, or both with variable involvement of esophagus, large intestine, or both.
Simon D, Wardlaw A, Rothenberg ME. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. The Journal of allergy and clinical immunology. 2010;126(1):3-13.
![Page 6: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/6.jpg)
Classification
Primary subtypes• Atopic • Nonatopic• Familial primary subtypes
Secondary subtypesEosinophilic disorders • Hypereosinophilic syndrome Noneosinophilic disorders • Celiac disease • Connective tissue disease
(scleroderma) • Iatrogenic • Infection • Inflammatory bowel disease • Vasculitis (Churg-Strauss
syndrome)
Mucosal, Muscularis,Serosal
Simon D, Wardlaw A, Rothenberg ME. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. The Journal of allergy and clinical immunology. 2010;126(1):3-13.
![Page 7: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/7.jpg)
Epidemiology
• Wide age range
Infancy Seventh decades
• Most commonly
Third Fifth decades
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
![Page 8: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/8.jpg)
Epidemiology
• An electronic survey sent to North American Allergists and Pediatric Gastroenterologists indicate prevalence for EGE of 22 to 28 per 100,000 persons
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. Journal of
pediatric gastroenterology and nutrition. 2011;52(3):300-6.
![Page 9: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/9.jpg)
Etiology
• Idiopathic
• Allergic mechanism
1. Increased total IgE and Food specific IgElevels
2.Increased T helper 2 associated cytokines
Simon D, Wardlaw A, Rothenberg ME. Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. The Journal of allergy and clinical immunology. 2010;126(1):3-13.
![Page 10: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/10.jpg)
Etiology
• Data from clinical studies suggest that patients with eosinophilic gastroenteritis have increased secretion of IL-4 and IL-5 by peripheral blood T cells.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 11: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/11.jpg)
Etiology
• T cells derived from the lamina propria of the duodenum of patients with EGID preferentially secrete Th2 cytokines (especially IL-13) when stimulated with milk proteins
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 12: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/12.jpg)
Etiology
• Mast cells are also increased in EGID.
• Recent murine model of oral allergen–induced diarrhea has indicated that mast cells have a critical role in the pathogenesis of allergic diarrhea in EGID.
Brandt EB, Strait RT, Hershko D, et al. Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003;112:1666-77.
![Page 13: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/13.jpg)
Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilicgastrointestinal allergy. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(12):6681-6.
Allergen sensitized mice
Challange with Oral allergen
•Marked allergen-specific IgG1and IgE, Th2-type (IL-4 and IL-5) cytokine production•Eosinophil accumulation in the blood and small intestine
Genetic absenceof eotaxin mice
(se (sensitized mice)
Challange with Oral allergen
•Eosinophil recruitment into small intestine was ablated •Enhanced eosinophilaccumulation in the blood compared with wild-type mice.
Genetic absenceof IL-5 mice
(sensitized mice)
Challange with Oral allergen
• Partial eosinophilaccumulation small intestine
•Decline in circulating eosinophil levels
![Page 14: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/14.jpg)
Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilicgastrointestinal allergy. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(12):6681-6.
Allergen sensitized mice
Challange with Oral allergen
•Marked allergen-specific IgG1and IgE, Th2-type (IL-4 and IL-5) cytokine production•Eosinophil accumulation in the blood and small intestine
Challange with Oral allergen
•Eosinophil recruitment into small intestine was ablated •Enhanced eosinophilaccumulation in the blood compared with wild-type mice.
Challange with Oral allergen
• Partial eosinophilaccumulation small intestine
•Decline in circulating eosinophil levels
These results establish that the accumulation ofgastrointestinal eosinophils is antigen induced, can occur independent of IL-5.
Genetic absenceof eotaxin mice
(se (sensitized mice)
Genetic absenceof IL-5 mice
(sensitized mice)
![Page 15: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/15.jpg)
EotaxinCC Chemokine Original name Chemokine
receptorMajor function
CCL 11 Eotaxin CCR3 Eosinophil,Basophil,TH2recruitment
CCL 24 Eotaxin-2 CCR3 Eosinophil,Basophil,TH2recruitment
CCL 26 Eotaxin-3 CCR3 Eosinophil,Basophil,TH2recruitment
![Page 16: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/16.jpg)
Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nature immunology. 2001;2(4):353-60.
•(OVA)-alum–sensitized mice were challenged with 2 doses of oral OVA in the form of enteric-coated beads•Mice developed eosinophil-associated GI dysfunction, including gastromegaly, delayed food transit, and weight loss, all strongly dependent on the chemokine eotaxin-1
![Page 17: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/17.jpg)
Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nature immunology. 2001;2(4):353-60.
•(OVA)-alum–sensitized mice were challenged with 2 doses of oral OVA in the form of enteric-coated beads•Mice developed eosinophil-associated GI dysfunction, including gastromegaly, delayed food transit, and weight loss, all strongly dependent on the chemokineeotaxin-1
Placebo
![Page 18: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/18.jpg)
Clinical Presentation
• Approximately 80% have symptoms for several years
• Occasionally, the disease may manifest itself as an
acute abdomen or bowel obstruction
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 19: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/19.jpg)
Clinical Presentation
Children & Adolescent
• Growth retardation
• Failure to thrive
• Delayed puberty or
amenorrhea.
Adults
• Abdominal pain
• Diarrhea
• Dysphagia
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 20: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/20.jpg)
Clinical Presentation
• Present with a constellation of symptoms that are related to the degree and area of the GI tract affected
1. Mucosal layer
2. Muscularis layer
3. Serosal layer
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 21: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/21.jpg)
Clinical Presentation
Mucosal disease
• Vomiting
• Abdominal pain
• Diarrhea
• Blood loss in stools
• Iron deficiency anemia
• Malabsorption
• Protein-losing enteropathy
• Failure to thrive
Chehade M, Magid MS, Mofidi S, Nowak-Wegrzyn A, Sampson HA, Sicherer SH. Allergic eosinophilicgastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-
up. Journal of pediatric gastroenterology and nutrition. 2006;42(5):516-21.
![Page 22: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/22.jpg)
Clinical Presentation
Muscle layer disease
Bowel wall thickening & Intestinal obstruction
Cramping & abdominal pain associated with nausea and vomiting
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 23: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/23.jpg)
Clinical Presentation
Subserosal disease
• Eosinophilic exudate ascites
• Abundant peripheral eosinophilia
• Serosal and visceral peritoneal inflammation leads to leakage of fluids
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 24: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/24.jpg)
Clinical Presentation
• EGE can occasionally involve the hepatobiliary
tree.
: Pancreatitis
: Cholangitis
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
![Page 25: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/25.jpg)
Diagnostic evaluation
• Laboratory
• Allergic evaluation
• Radiographic evaluation
• Endoscopic and Pathology
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 26: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/26.jpg)
Laboratory
• Complete blood count
• Serum albumin
• Fecal protein
• Stool examination
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 27: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/27.jpg)
Complete Blood Count
Peripheral blood eosinophilia Iron deficeicy anemia
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 28: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/28.jpg)
Complete Blood Count
Peripheral blood eosinophilia
Layer Average count
eosinophil/microltr
Mucosal 2,000
Muscular 1,000
Serosa 8,000
• Found in 20%-80% of cases
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 29: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/29.jpg)
Fecal protein
• Alpha1-antitrypsin in a 24-h feces collection
• Identify the inability to digest and absorb proteins in GI tract.
• The normal value is 0-54 mg/dL.
• Patients with eosinophilic gastroenteritis have elevated alpha1- antitrypsin in their feces.
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 30: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/30.jpg)
Stool examination
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
•Should be performed to rule out parasitic infestation.
•Mild-to-moderate steatorrhea is present approximately 30% of patients.
![Page 31: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/31.jpg)
Allergic evaluation
• Skin prick test
• Specific IgE antibody to inhaled & oral allergen
• Atopic patch testing
• Diagnostic trials of therapy with
1. Elimination
2. Oligoantigenic diets
3. Elemental (amino-acid based) diets
Khan S. Eosinophilic gastroenteritis. Best practice & research Clinical gastroenterology. 2005;19(2):177-98.
![Page 32: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/32.jpg)
Radiographic evaluation
Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE. Eosinophilic gastroenteritis: Clinical experience with 15 patients. World JGastroenterol 2003; 9(12): 2813-2816
![Page 33: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/33.jpg)
Endoscopic and Pathology
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 34: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/34.jpg)
![Page 35: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/35.jpg)
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
![Page 36: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/36.jpg)
Histology of The Stomach
higheredbcs.wiley.com
![Page 37: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/37.jpg)
Histology of The Stomach
Pathologyoutlines.com
Submucosa
Mucosa
Lamina propia
![Page 38: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/38.jpg)
Histology of The Intestine
![Page 39: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/39.jpg)
Histology of The Intestine
The organized tissues of the Peyer's patches and mesenteric lymph nodes (MLNs) are involved in the induction of immunity and tolerance, whereas the effector sites are scattered throughout the lamina propriaand epithelium of the mucosa. Both the Peyer's patches and villus lamina propria are drained by afferent lymphatics that go to the MLNs. SED, subepithelial dome; TDA, thymus-dependent area.
![Page 40: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/40.jpg)
Gastrointestinal Eosinophils Under Homeostatic Healthy States
• Eosinophils are present at low levels in numerous tissues
• In biopsy and autopsy specimens, organs that normally demonstrate tissue eosinophils at substantial levels are
- GI tract - Lymph nodes
- Spleen - Thymus
DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatric and developmental pathology : the official journal of the
Society for Pediatric Pathology and the Paediatric Pathology Society. 2006;9(3):210-8.
![Page 41: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/41.jpg)
Gastrointestinal Eosinophils Under Homeostatic Healthy States
• Eosinophils throughout the GI tract of conventional healthy mice : normally present in the lamina propria of the stomach, small intestine, cecum, and colon.
• Eosinophils are not normally present in Peyerpatches or intraepithelial locations.
• Eosinophils are frequently infiltrate in Peyerpatches regions in EGID.
Mishra A, Hogan SP, Lee JJ, et al. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J ClinInvest 1999;103: 1719-27
Rothenberg ME, Mishra A, Collins MH, et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy ClinImmunol 2001;108:891-4.
![Page 42: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/42.jpg)
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 43: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/43.jpg)
DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatric and developmental pathology : the official journal of the
Society for Pediatric Pathology and the Paediatric Pathology Society. 2006;9(3):210-8.
![Page 44: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/44.jpg)
Histology of The Intestine
Normal Duodenum histology
Pathologyoutlines.com
![Page 45: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/45.jpg)
Histology of The Intestine
Normal Colon histologyPathologyoutlines.com
![Page 46: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/46.jpg)
Histology of The Intestine
Normal Colon histology
Embryology.med.unsw.ed
![Page 47: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/47.jpg)
Endoscopic and Pathology
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
Dense eosinophilicinfiltrates in the lamina propria and mucosae
![Page 48: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/48.jpg)
Endoscopic and Pathology
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
Dense eosinophilicinfiltrates in the lamina propria and mucosae
![Page 49: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/49.jpg)
Endoscopic and Pathology
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
Dense eosinophilicinfiltrates in the lamina propria and mucosae
![Page 50: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/50.jpg)
Dense eosinophilicinfiltrates in the lamina propria and mucosae
![Page 51: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/51.jpg)
No standards exist for diagnosis
The following findings support the diagnosis
1.Presence of elevated eosinophils in
biopsy specimens from the GI tract
wall
2. Infiltration of eosinophils within
intestinal crypts and gastric glands
3. Lack of involvement of other organs
4. Exclusion of other causes of
eosinophilia
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 52: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/52.jpg)
g
•Gross Endoscoopic finding are often normal•Endoscopic bx should be obtained from 5-6 site of afffected organ
•In stomach eosinophillevels>30 eo/HPF differrentiate eosinophilicgastritis from normal adult control
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
![Page 53: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/53.jpg)
No standards exist for diagnosis
Four criteria are required for the diagnosis
1. Presence of gastrointestinal symptoms
2. Eosinophilic infiltration of gastrointestinal tract
3. Exclusion of parasitic disease
4. Absence of other systemic involvement
Ingle SB, Hinge Ingle CR. Eosinophilic gastroenteritis: an unusual type of gastroenteritis. World journal of gastroenterology : WJG. 2013;19(31):5061-6.
![Page 54: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/54.jpg)
Treatment
• Eliminating the dietary intake of foods implicated by skin-prick tests
• Drugs
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 55: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/55.jpg)
Chehade M, Magid MS, Mofidi S, Nowak-Wegrzyn A, Sampson HA, Sicherer SH. Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up. Journal of pediatric
gastroenterology and nutrition. 2006;42(5):516-21.
6 6 Pts with AEG with PLE
6 Pts with AEG
5 Pts with
Abd S/S with Bx -ve
Medical records of patients were reviewed for clinical history, physical ,laboratory values.
![Page 56: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/56.jpg)
Chehade M, Magid MS, Mofidi S, Nowak-Wegrzyn A, Sampson HA, Sicherer SH. Allergic eosinophilicgastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-
up. Journal of pediatric gastroenterology and nutrition. 2006;42(5):516-21.
![Page 57: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/57.jpg)
Chehade M, Magid MS, Mofidi S, Nowak-Wegrzyn A, Sampson HA, Sicherer SH. Allergic eosinophilicgastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-
up. Journal of pediatric gastroenterology and nutrition. 2006;42(5):516-21.
![Page 58: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/58.jpg)
Chehade M, Magid MS, Mofidi S, Nowak-Wegrzyn A, Sampson HA, Sicherer SH. Allergic eosinophilicgastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-
up. Journal of pediatric gastroenterology and nutrition. 2006;42(5):516-21.
6 Pts with AEG with PLE
•Pts had excellent response to therapy with amino acid based formula and tolerated gradualintroduction of some foods with time.
![Page 59: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/59.jpg)
Eliminating the dietary intake of foods
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
Dietary modification
Disease remission
Specific food groups are slowly reintroduced, at about 3-week intervals for each food group
Endoscopy is performed every 3 months to identify either sustained remission or disease
flare-up
![Page 60: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/60.jpg)
Treatment
• Cromoglycate
• Montelukast
• Ketotifen
• Suplatast tosilate
• Mycophenolate mofetil (inosinemonophosphate dehydrogenase inhibitor)
• Alternative Chinese medicines
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 61: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/61.jpg)
Treatment
• Cromoglycate
• Montelukast
• Ketotifen
• Suplatast tosilate
• Mycophenolate mofetil (inosinemonophosphate dehydrogenase inhibitor)
• Alternative Chinese medicines
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
Generally unsuccessful
![Page 62: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/62.jpg)
Treatment
• Suplatast tosilate
:Anti-Th2 drug
:Inhibits the expression of Th2 cytokines, such as IL-5.
:Successful treatment of EGE with suplatasthas been described in 2 single patient case reports.
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
![Page 63: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/63.jpg)
Treatment
• Anti-inflammatory drugs
:Systemic steroids
:Topical steroids
• Anti–IL-5
• Anti-IgE
• Azathioprine or 6-mercaptopurine
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 64: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/64.jpg)
Antiinflammatory drugs
• If diet restriction is not feasible or has failed to improve the disease.
• As with treatment for asthma, topical steroids have a better benefit-to-risk effect than systemic steroids.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 65: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/65.jpg)
Anti-inflammatory drugs
• Systemic steroid therapy
: A course of 2 to 6 weeks with relatively low doses seems to work better than a 7-day course of burst glucocorticoids.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 66: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/66.jpg)
Anti-inflammatory drugs
• Topical glucocorticoids
:Budesonide tablets (Entocort EC) are designed to deliver the drug to the ileum and proximal colon.
:As with treatment for asthma, topical steroids have a better benefit-to-risk effect than systemic steroids.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 67: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/67.jpg)
Patient profile: A 32-year-old Caucasian woman
Present illness: Admitted to hospital with complaints of recurrent
cramping pain in the upper abdomen associated
with nausea and non-bloody diarrhoea. She had
lost 4 kg in weight.
Past history : No history of food intolerance, allergy, travel
to tropical areas, or prior medication
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 68: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/68.jpg)
Physical examination:
Slightly enlarged belly with normal bowel sounds.
Laboratory data:
Hb 8.1 mmol/l
WBC 29x109/l Eosinophil 69%.
Total serum protein 67.3 g/l.
Immunoglobulins:normal.
Echography : ascitic fuid.
Upper gastrointestinal endoscopy (biopsies):normal
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 69: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/69.jpg)
Problem list: Eosinophilia and Ascitic fuid
Strong suspicious :Eosinophilic gastroenteritis of the serosal
type
Treatment: Prednisolone 40 mg/day was initiated
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 70: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/70.jpg)
Clinical course:
- A rapid dissolution of complaints and a decrease in the eosinophilic count.
- After tapering and eventually stopping the prednisone medication, the patient remained without complaints for over 1 year.
- Then she experienced more complaints of diarrhoea
and ascites. Total eosinophilic count was markedly
increased
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 71: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/71.jpg)
Clinical course:
- To ascertain the diagnosis of eosinophilic gastroenteritis
- A full-thickness surgical antrum biopsy was taken.
- Histology revealed eosinophilic granulocytic infiltration in
the muscular mucosa .
- In the ascitic fuid, an inflammatory response with
eosinophilic granulocytes
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 72: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/72.jpg)
Clinical course:
-Prednisone was started at a dose of 25 mg, with rapid
dissolution of complaints and peripheral eosinophilia.
-When the prednisone dose was tapered to 5 mg/day, the
patient complained of crampy abdominal pain and
diarrhoea.
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 73: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/73.jpg)
Clinical course:
-We gave budesonide tablets, normally used for the
preparation of the budesonide clysma.
-Starting dose was 4 mg daily, with a good clinical effect.
- With this treatment regimen, the patient has been in
remission for more than 2 years.
Tan AC, Kruimel JW, Naber TH. Eosinophilic gastroenteritis treated with non-enteric-coated budesonidetablets. European journal of gastroenterology & hepatology. 2001;13(4):425-7.
![Page 74: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/74.jpg)
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
Initiated using prednisone at 0.4 to 0.8 mg/kg each morning
+Solubilized budesonide is begun at 9 mg orally daily, taken at bedtime on an empty stomach
Prednisone is tapered over the next 2 or more weeks
clinical symptoms are controlled
•One to 2 months after the prednisone has been stopped•Budesonide dose is slowly tapered over an additional 2 to 4 months to
the minimum required dose.
clinical symptoms are controlled
![Page 75: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/75.jpg)
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
Initiated using prednisone at 0.4 to 0.8 mg/kg each morning
+Solubilized budesonide is begun at 9mg orally daily, taken at bedtime on an empty stomach
Prednisone is tapered over the next 2 or more weeksclinical symptoms
are controlled
•One to 2 months after the prednisone has been stopped•Budesonide dose is slowly tapered over an additional 2 to 4 months to
the minimum required dose.
clinical symptoms are controlled
![Page 76: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/76.jpg)
Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG, et al. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. The Journal of allergy and clinical immunology. 2007;120(3):594-601.
Nine EGE pts
3 wks pre Omalizumab
baseline screen
16 wks Omalizumab q 2 wks
Repeat all baseline study
![Page 77: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/77.jpg)
![Page 78: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/78.jpg)
Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG, et al. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. The Journal of allergy and clinical immunology. 2007;120(3):594-601.
Omalizumab was associated with decrease in absolute eosinophilcount :at week 16 (34%, P = 0.004): combined weeks 12 to 16 (42%, P = 0.012)
![Page 79: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/79.jpg)
Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG, et al. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. The Journal of allergy and clinical immunology. 2007;120(3):594-601.
Tissue eosinophils decreased in the duodenum (59%) and gastric antrum (69%) but did not reach statistical significance (P 0.074 and 0.098, respectively).
![Page 80: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/80.jpg)
Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG, et al. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. The Journal of allergy and clinical immunology. 2007;120(3):594-601.
Symptom scores weredecreased at both the midstudy (63%) and end of study (70%) time points (P < .005 for both)
![Page 81: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/81.jpg)
Anti–IL-5
Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterology clinics of North America. 2014;43(2):317-27.
Reslizumab
• an open-label clinical trial of reslizumab (SCH55700) was undertaken in 4 subjectswith EGE.• Reslizumab suppressed blood eosinophilia in a significant manner. • tissue eosinophilia was only modestly suppressed •EGE symptoms were minimally affected.
![Page 82: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/82.jpg)
Eosinophilic Colitis
![Page 83: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/83.jpg)
Eosinophilic Colitis
• Introduction
• Classification
• Epidemiology
• Etiology
• Clinical Presentation
• Diagnostic evaluation
• Treatment
![Page 84: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/84.jpg)
Introduction
• Eosinophils accumulate in the colon of patients with a variety of disorders
: Eosinophilic gastroenteritis
: Allergic colitis of infancy
: Infections (e.g., pinworms, dog hookworms)
: Drug reactions
: Vasculitis (e.g., Churg-Strauss syndrome)
: IBD
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 85: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/85.jpg)
Classification
Primary subtypes• Atopic • Nonatopic
Secondary subtypesEosinophilic disorders • Hypereosinophilic syndrome Noneosinophilic disorders • Celiac disease • Connective tissue disease
(scleroderma) • Iatrogenic • Infection • Inflammatory bowel disease • Vasculitis (Churg-Strauss
syndrome)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 86: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/86.jpg)
Allergic colitis in infancy
• Cow’s milk and soy proteins are the foods most frequently implicated in allergic colitis of infancy
• This condition may occur more often in infants exclusively breastfed and can even occur in infants fed with protein hydrolysate formulas
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 87: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/87.jpg)
Allergic colitis in infancy
• Dietary protein– induced proctocolitis of infancy syndrome
• Most common cause of bloody stools in the first year of life
• An early expression of protein-induced enteropathyor protein-induced enterocolitis syndrome.
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 88: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/88.jpg)
Etiology
• A non- IgE–associated disease
• Some studies point to a T lymphocyte– mediated process.
• Exact immunologic mechanisms responsible for this condition have not been identified.
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 89: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/89.jpg)
Clinical Presentation
• Bimodal age distribution
:Infantile
:Early adolescent and Adulthood
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 90: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/90.jpg)
Clinical Presentation
• Diarrhea
• Abdominal pain
• Weight loss
• Anorexia
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 91: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/91.jpg)
Differential diagnosis of EC
Okpara N, Aswad B, Baffy G. Eosinophilic colitis. World journal of gastroenterology : WJG. 2009;15(24):2975-9.
![Page 92: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/92.jpg)
Diagnostic evaluation
• No single test is the “gold standard” for diagnosis
• Peripheral blood eosinophilia or eosinophils in the stool suggests eosinophilic colitis.
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 93: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/93.jpg)
Endoscopic and Pathology
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
• Patchy erythema
• Loss of vascularity,
• Lymphonodularhyperplasia
mostly localized to the rectum but might extend to the entire colon
Gastroenterol Res Pract. 2011
![Page 94: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/94.jpg)
Endoscopic and Pathology
Okpara N, Aswad B, Baffy G. Eosinophilic colitis. World journal of gastroenterology : WJG. 2009;15(24):2975-9.
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
• Patchy erythema
• Loss of vascularity,
• Lymphonodularhyperplasia
mostly localized to the rectum but might extend to the entire colon
![Page 95: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/95.jpg)
Histology of The Intestine
Normal Colon histology
![Page 96: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/96.jpg)
Endoscopic and Pathology
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology.
2004;113(1):11-28.
• Overall architecture of the mucosa is well preserved
• Focal aggregates of eosinophils in the lamina propria, crypt epithelium, and muscularis mucosa,
• Multinucleated giant cells are occasionally present in the submucosa.
Okpara N, Aswad B, Baffy G. Eosinophilic colitis. World journal of gastroenterology : WJG. 2009;15(24):2975-9.
![Page 97: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/97.jpg)
Endoscopic and Pathology
Gastroenterol Res Pract. 2011
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
• Overall architecture of the mucosa is well preserved
• Focal aggregates of eosinophils in the lamina propria, crypt epithelium, and muscularis mucos.,
• Multinucleated giant cells are occasionally present in the submucosa.
![Page 98: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/98.jpg)
Treatment
• Eosinophilic colitis of infancy
:Benign disease
:Withdrawal of the offending protein trigger from the diet
-->the gross blood in the stools usually resolves within 72 hours
--> occult blood loss may persist longer
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 99: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/99.jpg)
Treatment
• Eosinophilic colitis of older
:Usually requires medical management because IgEassociated triggers are rarely identified.
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 100: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/100.jpg)
Treatment
• Eosinophilic colitis of older
: Cromoglycate ,Montelukast,Histamine receptor antagonists : generally unsuccessful
:Aminosalicylates and systemic or topical glucocorticoids :typically used and appear to be efficacious
:Azathioprine or 6-mercaptopurine: in severe cases
Rothenberg ME. Middleton's Allergy ; 8th edition. 2014. p. 1095-1106
![Page 101: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/101.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 102: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/102.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 103: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/103.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
EGID are generally tissue-
specific problems
HES tends to involve the heart,
lungs, and skin
![Page 104: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/104.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
Eosinophilic esophagitis(EoE), a disease
mechanistically linked with eosinophilic airway
inflammation (asthma).
![Page 105: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/105.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
Eosinophilicgastroenteritis,
specific regions of the GI tract may be selectively involved
![Page 106: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/106.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 107: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/107.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 108: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/108.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 109: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/109.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.
![Page 110: Eosinophilic gastrointestinal disorders (part II)](https://reader034.fdocuments.in/reader034/viewer/2022042716/55a6e6b31a28abfb318b4695/html5/thumbnails/110.jpg)
Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). The Journal of allergy and clinical immunology. 2004;113(1):11-28.